AnandRathi

Neuland Laboratories Ltd Fundamental Analysis

Last Updated Date: 27 Aug 2026
23,492.85
-64.35 (-0.27%)

Neuland Laboratories Ltd (Neuland Labs.) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹30,141 crore.

Neuland Laboratories Ltd Overview

Market cap₹30,141 Crs
Volume1,474
Prev. Close₹23,557.20
Year range₹11,500.00 - ₹23,899.00
Total Value₹3,46,28,460.90
ISININE794A01010

Neuland Laboratories Ltd Fundamental Analysis

ROCE(TTM)23.61%
P/E Ratio (TTM)60.68
P/B Ratio16.16
Debt to Equity0.16
ROE19.46%
EPS (TTM)387.19
Dividend Yield0.15%
Book Value1453.59
Profit Margin20.94%
Operating Margin27.97%

Neuland Laboratories Ltd Historical Performance

1 Month Return23.81%
6 Month Return83.44%
3 Year Return513.90%
3 Month Return40.18%
1 Year Return78.37%
5 Year Return1297.88%

Neuland Laboratories Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research